BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,020.00
+25.00 (0.50%)
At close: Apr 3, 2026
BioNote Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -87,498 | 55,261 | -20,497 | 307,798 | 676,601 |
Depreciation & Amortization | 9,227 | 8,186 | 8,206 | 6,451 | 4,106 |
Loss (Gain) From Sale of Assets | 1,671 | -20.25 | -265.2 | -13,412 | -361,225 |
Asset Writedown & Restructuring Costs | - | 4,835 | 8,409 | - | - |
Loss (Gain) From Sale of Investments | -1,907 | -9,386 | 5,000 | 5,150 | -15,047 |
Loss (Gain) on Equity Investments | 112,718 | 4,987 | 83,791 | -77,260 | - |
Stock-Based Compensation | 264.8 | 99.92 | - | 1,637 | 1,985 |
Provision & Write-off of Bad Debts | 901.33 | 62.32 | -2,845 | -3,596 | 6,827 |
Other Operating Activities | -17,992 | -12,749 | -82,440 | -4,089 | 34,137 |
Change in Accounts Receivable | -10,089 | -2,934 | 855.57 | 73,437 | 220,048 |
Change in Inventory | 7,697 | 10,632 | -436.63 | -33,543 | -9,826 |
Change in Accounts Payable | 1,622 | -982.63 | 221.23 | -4,573 | -22,140 |
Change in Other Net Operating Assets | -2,234 | -74.32 | -4,193 | -8,901 | 1,926 |
Operating Cash Flow | 14,381 | 57,917 | -4,194 | 249,100 | 537,392 |
Operating Cash Flow Growth | -75.17% | - | - | -53.65% | 123.98% |
Capital Expenditures | -8,111 | -10,462 | -3,963 | -42,266 | -51,425 |
Sale of Property, Plant & Equipment | 7,675 | 727.18 | 94.36 | 49,399 | 174.43 |
Cash Acquisitions | - | - | - | - | -6,266 |
Sale (Purchase) of Intangibles | -158.52 | -19.66 | -579.33 | -217.44 | -118.58 |
Investment in Securities | -77,416 | -72,415 | -477,108 | -37,446 | -133,747 |
Other Investing Activities | 0 | 0 | 0 | - | - |
Investing Cash Flow | -78,011 | -82,170 | -481,555 | -30,530 | -191,383 |
Short-Term Debt Issued | - | - | 150,000 | - | - |
Long-Term Debt Issued | - | - | 10.5 | 50 | - |
Total Debt Issued | - | - | 150,011 | 50 | - |
Short-Term Debt Repaid | - | - | -150,000 | - | - |
Long-Term Debt Repaid | -1,282 | -1,144 | -836 | -415.58 | -216.76 |
Total Debt Repaid | -1,282 | -1,144 | -150,836 | -415.58 | -216.76 |
Net Debt Issued (Repaid) | -1,282 | -1,144 | -825.5 | -365.58 | -216.76 |
Issuance of Common Stock | - | - | 843.66 | 73,280 | - |
Repurchase of Common Stock | -5,001 | -3,108 | - | - | - |
Dividends Paid | -20,272 | -20,411 | -49,919 | -49,959 | -49,959 |
Other Financing Activities | - | - | - | -0 | -420 |
Financing Cash Flow | -26,555 | -24,663 | -49,901 | 22,955 | -50,596 |
Foreign Exchange Rate Adjustments | 714.29 | 8,862 | 1,978 | 20,930 | 118.56 |
Net Cash Flow | -89,470 | -40,054 | -533,672 | 262,455 | 295,532 |
Free Cash Flow | 6,270 | 47,454 | -8,156 | 206,834 | 485,966 |
Free Cash Flow Growth | -86.79% | - | - | -57.44% | 127.91% |
Free Cash Flow Margin | 5.30% | 46.17% | -9.05% | 43.12% | 78.09% |
Free Cash Flow Per Share | 61.99 | 465.43 | -79.98 | 2193.65 | 5186.94 |
Cash Interest Paid | 287.11 | 233.55 | 602.82 | 84.44 | 44.25 |
Cash Income Tax Paid | 16,406 | 5,003 | 40,454 | 157,006 | 171,252 |
Levered Free Cash Flow | -5,922 | 14,076 | -18,697 | 129,964 | 399,410 |
Unlevered Free Cash Flow | -5,743 | 14,222 | -18,321 | 130,017 | 399,438 |
Change in Working Capital | -3,004 | 6,640 | -3,553 | 26,420 | 190,009 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.